Method for preparing chloramphenicol from 4-chloro-benzaldehyde

A technology of chloramphenicol and chlorophenyl, which is applied in the field of compound preparation, can solve the problems of long synthetic route of chloramphenicol, production cost and increase of three wastes, etc., achieves easy availability and low price of raw materials, solves the problem of three wastes and yields high effect

CN102399163AActive Publication Date: 2012-04-04GRAND PHARM (CHINA) CO LTD
2 Cites 4 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2012-04-04

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a method for preparing a broad spectrum antibiotic of chloramphenicol. The method comprises the following steps of: synthesizing (1R,2R)-2-nitro-1-(4-chlorophenyl)-1,3-propanediol by using 4-chlorobenzaldehyde and 2-nitroethylalcohol as raw materials in the presence of a chiral catalyst, and performing catalytic hydrogenation to obtain (1R,2R)-2-amino-1-(4-chlorophenyl)-1,3-propanediol; and performing nitro substitution and dichloro acetylization on the intermediate to obtain the chloramphenicol. By the method, the common chiral resolution and aluminum isopropoxide reduction in the industry at present can be avoided, three wastes are reduced, the raw materials and reagents are cheap and readily available, p-chlorobenzaldehyde is selected as a raw material, the method comprises a few synthesizing steps, the yield is high, and the method is suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a preparation method of a compound, in particular to a method for preparing chloramphenicol from 4-chlorobenzaldehyde. Background technique

[0002] Chlorotoxin is a broad-spectrum antibiotic, mainly used for typhoid bacillus, Shigella, meningococcus, pneumococcus infection, and can also be used for rickettsial infection. Although it has many side effects such as inhibition of bone marrow hematopoietic function, causing coarse cells and thrombocytopenia or aplastic anemia, it is still the drug of choice for the treatment of typhoid fever.

[0003] Chloramphenicol is white or slightly yellow-green needle-like, long flaky crystals or crystalline powder. Bitter. The melting point is 149-153°C. Soluble in organic solvents such as methanol, ethanol and acetone, slightly soluble in water. Specific rotation [α] D 25 =+18.5~+21.5° (absolute ethanol).

[0004] There are many reports about the synthetic route of chloramphenicol, b...

Examples

Embodiment 1

[0034] The preparation of embodiment 1 (1R, 2R)-2-nitro-1-(4-chlorophenyl)-1,3-propanediol

[0035] 1.8 g of Cu(OTf) 2 (0.50mmol), 2.4 grams of ligand (5.2mmol) and 40 milliliters of 1,4-dioxane were added in a 250 milliliter single-necked flask, and the nitrogen flow was kept constant after replacing the air inside with nitrogen, and at room temperature, magnetically stirred for 2 After one hour, cool with an ice bath, add 7.0 grams of 4-chlorobenzaldehyde (50mmol), 45.5 grams of 2-nitroethanol (500mmol) and N-methylmorpholine (0.54 milliliters, 5.0mmol) successively, and the reaction solution is placed in an ice bath Stir at 0 to 5°C for about 24 hours. After no raw material 4-chlorobenzaldehyde spots are detected by thin-plate chromatography, the volatile solvent is removed by distillation under reduced pressure, the catalyst is removed by silica gel filtration, and the filtrate is concentrated to obtain 10.6 grams of the product, with a yield of 91.8%. , HPLC measured e.e...

Embodiment 2

[0036] Example 2 Preparation of (1R, 2R)-2-nitro-1-(4-chlorophenyl)-1,3-propanediol 2

[0037] 0.8 g of Cu(OTf) 2 (0.50mmol), 0.8 gram of rhodium acetate, 1.2 gram of 2,6-bis[(S)-4-isopropyl-1-phenyl-4,5-dihydro-1H-2-imidazolyl]pyridine (5.2 mmol) and 20 milliliters of 1,4-dioxane were added in a 250 milliliter single-necked flask, and the nitrogen flow was kept constant after replacing the air inside with nitrogen. At room temperature, magnetically stirred for 2 hours and then cooled with an ice bath, and then added 7.0 grams of 4-Chlorobenzaldehyde (50mmol), 45.5 grams of 2-nitroethanol (500mmol) and 0.15 grams of picoline, the reaction solution was stirred in an ice bath at 4°C for about 20 hours, and no raw material 4-chlorobenzaldehyde was detected by thin-plate chromatography After spotting, the volatile solvent was then distilled off under reduced pressure, the catalyst was removed by silica gel filtration, and the filtrate was concentrated to obtain 10.9 grams of prod...

Embodiment 3

[0038] Example 3 Preparation of (1R, 2R)-2-nitro-1-(4-chlorophenyl)-1,3-propanediol 3

[0039] 1.8 g of Cu(OTf) 2(0.50mmol), 2.4 grams of 2,6-bis[(S)-4-isopropyl-1-phenyl-4,5-dihydro-1H-2-imidazolyl]pyridine (5.2mmol) and 40 ml Add 1,4-dioxane into a 250 ml single-necked flask, replace the air inside with nitrogen and keep the nitrogen flow constant. At room temperature, stir magnetically for 2 hours and cool in an ice bath, then add 6.0 g of 4-bromobenzaldehyde in turn , 45.5 grams of 2-nitroethanol (500mmol) and N-methylmorpholine (0.54 milliliters, 5.0mmol), the reaction solution was stirred in an ice bath at 4°C for about 30 hours, and no raw material 4-chlorobenzaldehyde was detected by thin plate chromatography After spotting, the volatile solvent was then distilled off under reduced pressure, the catalyst was removed by silica gel filtration, and the filtrate was concentrated to obtain 9.6 grams of product, with a yield of 86.2%. The e.e value of HPLC was 92.9%. 1H), ...